Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An invasive malignant neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia. It includes serous adenocarcinoma and serous adenocarcinofibroma.
Biomarker and diagnostic research for malignant ovarian serous tumor has been reported in the published literature.
No clinical trials have been registered for malignant ovarian serous tumor.
231 publications have been identified in PubMed for malignant ovarian serous tumor. Kisho has analyzed 89 by research type. Research spans Basic Science / Preclinical (54%), Review / Meta-Analysis (20%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 48 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:51 AM UTC
Research summaries |
18 |
20% |
Disease patterns and progression | 8 | 9% |
Testing and diagnosis research | 6 | 7% |
New treatment approaches | 5 | 6% |
Clinical study results | 4 | 4% |
Shao C (2026). [PMID: 41193244](https://pubmed.ncbi.nlm.nih.gov/41193244/). *Genes Dev*. [Basic Science / Preclinical]
Liu D (2026). [PMID: 41734034](https://pubmed.ncbi.nlm.nih.gov/41734034/). *J Clin Invest*. [Basic Science / Preclinical]
Liu Q (2026). [PMID: 41526347](https://pubmed.ncbi.nlm.nih.gov/41526347/). *Nat Commun*. [Basic Science / Preclinical]
Pundel OJ (2026). [PMID: 41052931](https://pubmed.ncbi.nlm.nih.gov/41052931/). *Cold Spring Harb Perspect Med*. [Review / Meta-Analysis]
Sandrasegaran K (2026). [PMID: 40748460](https://pubmed.ncbi.nlm.nih.gov/40748460/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Micoli G (2025). [PMID: 40736012](https://pubmed.ncbi.nlm.nih.gov/40736012/). *Cancer Discov*. [Basic Science / Preclinical]
Franciosa G (2025). [PMID: 40204276](https://pubmed.ncbi.nlm.nih.gov/40204276/). *Mol Cell Proteomics*. [Epidemiology / Natural History]
Shen D (2025). [PMID: 39754905](https://pubmed.ncbi.nlm.nih.gov/39754905/). *Cancer Genet*. [Gene Therapy / Novel Therapeutics]
Zannoni GF (2025). [PMID: 40508029](https://pubmed.ncbi.nlm.nih.gov/40508029/). *Int J Mol Sci*. [Review / Meta-Analysis]
Caruso G (2025). [PMID: 40690248](https://pubmed.ncbi.nlm.nih.gov/40690248/). *JAMA*. [Review / Meta-Analysis]